---
title: Lonza Cell & Gene Technologies vs Northway Biotech
slug_a: lonza
slug_b: northway-biotech
site: cdmo
review_signal_gate: closed
canonical_path: /compare/lonza/northway-biotech
generated_by: BioBM Editorial AI
---

# Lonza Cell & Gene Technologies vs Northway Biotech

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Lonza Cell & Gene Technologies (lonza) is listed for cdmo. Lonza is the world's leading CDMO, founded in Switzerland in 1897, serving the healthcare industry with integrated offerings for contract development and manufacturing of therapies across multiple modalities.

Services: 20. Modalities: 4. Indications: 0. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (20).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Northway Biotech (northway-biotech) is listed for cdmo. End-to-end CDMO specializing in protein-based biologics and gene therapies, with 20+ years of expertise and cGMP facilities in Lithuania and Massachusetts supporting development from preclinical to commercial stages.

Services: 11. Modalities: 2. Indications: 1. Locations: 2. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (11).

Review summary: Review summary withheld until site-level review gate opens.